







Genomics has undergone a major shift in the last year. The drop in price in the past decade from $3B to $1K to sequence a genome is the 10X force likely to cause an inflection point in a number of health-related industries. But despite the price, right now genomics is a niche product in large part used in and promoted by academia.
DEF CON 25 - John Sotos - Genetic Diseases to Guide Digital Hacks of the Human Genome
Experts Held a Secret Meeting to Consider Building a Human Genome From Scratch
Earlier this week, over a hundred scientists, lawyers, and entrepreneurs gathered to discuss the radical possibility of creating a synthetic human genome.

23andMe Is Terrifying but Not for the Reasons the FDA Thinks
This genetic testing company’s real goal is to hoard your personal data

Ginkgo Bioworks (NYSE:DNA) Trying to Prevent Future Man-Made Biological Threats
Synthetic biology firm Ginkgo Bioworks has developed tools that US intelligence agencies can use to detect engineered DNA at scale, a milestone that could better protect the nation from human-made biological threats. The new software could be used to provide an early warning of bioweapons, such as a new deadly bacteria, or a modified virus that thwarts existing vaccines.

Biotech company Regeneron to buy bankrupt 23andMe for $256M
Regeneron will use trove of 23andMe genetic data to develop medical advances.

The Genesis Engine
Editing DNA is now cut-and-paste. We could eliminate disease, cure hunger—or break the world.

Ancestry.com can use your DNA to target ads - CITP Blog
With the reduction in costs of genotyping technology, genetic genealogy has become accessible to more people. Various websites such as Ancestry.com offer genetic genealogy services. Users of these services are mailed an envelope with a DNA collection kit, in which users deposit their saliva. The users then mail their kits back to the service and […]
The Evolution Of The Biohacking Ecosystem | TechCrunch
Silicon Valley efforts in the biology and health domains have recently seen increased public interest because of the questions around the legitimacy of Theranos' technology and medical claims and the recent FDA approvals for a number of 23andMe's genetic screens. These data points are just two of the most visible examples of a broad ecosystem of companies and startups in Silicon Valley working on biological problems.

How the microbiome will lead a revolution in the consumerization of personalized medicine and diet | TechCrunch
The human microbiome -- meaning all of our microbes’ genes -- will reshape the consumerization of personalized medicine and diet. Following the human genome project, technological advancements have brought us much closer to acute precision in disease diagnosis and treatment. The microbiome has the potential to change the way we diagnose and treat the most critical diseases of our time.

On #CRISPR gene drives, the human cost of anti-science, dangers of closed-door science, & more: @kesvelt @ #EAGlobal https://t.co/HLzzOE1Fut
On #CRISPR gene drives, the human cost of anti-science, dangers of closed-door science, & more: @kesvelt @ #EAGlobal https://t.co/HLzzOE1Fut— MIT Media Lab (@medialab) August 24, 2016
Monsanto Just Got Access to the World’s Most Powerful Gene-Editing Tool
Agriculture company Monsanto has acquired a non-exclusive global licensing agreement from MIT’s Broad Institute and Harvard to use the CRISPR/Cas9

The contract between science and society, plus a possible new Renaissance
Genomics may accomplish a lot, but could it redefine humanity's view of itself?

AlphaGenome Atlas: a high-resolution map of human DNA
We’re introducing AlphaGenome Atlas, a database predicting the effects of every possible single nucleotide variant in the human genome.

Scientists Have Created A New Gene-Editing Tool That Could Outperform CRISPR
It is faster and simpler than CRISPR, enabling millions of genetic experiments to be performed simultaneously.

BioCoder
Chronicling stories on those who are making biology research and tools more accessible, collaborative, low-cost, and efficient

(PDF) Highly efficient genome editing using oocyte-specific z cas9 transgenic zebrafish
PDF | Since its first application, CRISPR/Cas9 rapidly becomes a routine technique to perform genome editing in a variety of biological systems. To... | Find, read and cite all the research you need on ResearchGate
